Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/439
DC FieldValueLanguage
dc.contributor.authorGarcía, Salvadores
dc.contributor.authorLagos, Rosannaes
dc.contributor.authorMuñoz, Almaes
dc.contributor.authorPicón, Teresaes
dc.contributor.authorRosa, Raqueles
dc.contributor.authorAlfonso, Adrianaes
dc.contributor.authorAbriata, Gracielaes
dc.contributor.authorGentile, Angelaes
dc.contributor.authorRomanin, Vivianaes
dc.contributor.authorRegueira, Mabeles
dc.contributor.authorChiavetta, Lauraes
dc.contributor.authorAgudelo, Clara Inéses
dc.contributor.authorCastañeda, Elizabethes
dc.contributor.authorDe la Hoz, Fernandoes
dc.contributor.authorHiguera, Ana Bettyes
dc.contributor.authorArce, Patriciaes
dc.contributor.authorCohen, Adam L.es
dc.contributor.authorVerani, Jenniferes
dc.contributor.authorZuber, Patrickes
dc.contributor.authorGabastou, Jean-Marces
dc.contributor.authorPastor, Desireees
dc.contributor.authorFlannery, Brendanes
dc.contributor.authorAndrus, Jones
dc.date.accessioned2013-03-21T00:51:02Z-
dc.date.available2013-03-21T00:51:02Z-
dc.date.issued2012-01-05-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/439-
dc.descriptionFil: García, Salvador. Pan American Health Organization, Washington DC; Estados Unidos.es
dc.descriptionFil: Lagos, Rosanna. Centro para Vacunas en Desarrollo (CVD-Chile), Santiago; Chile.es
dc.descriptionFil: Muñoz, Alma. Centro para Vacunas en Desarrollo (CVD-Chile), Santiago; Chile.es
dc.descriptionFil: Picón, Teresa. National Immunization Program and Department of Epidemiologic Surveillance, Ministry of Health, Montevideo; Uruguay.es
dc.descriptionFil: Rosa, Raquel. National Immunization Program and Department of Epidemiologic Surveillance, Ministry of Health, Montevideo; Uruguay.es
dc.descriptionFil: Alfonso, Adriana. National Immunization Program and Department of Epidemiologic Surveillance, Ministry of Health, Montevideo; Uruguay.es
dc.descriptionFil: Abriata, Graciela. Instituto Nacional del Cáncer, Ministerio de Salud de la Nación, Buenos Aires; Argentina.es
dc.descriptionFil: Gentile, Angela. Hospital de Niños Ricardo Gutierrez, Epidemiología, Buenos Aires; Argentina.es
dc.descriptionFil: Romanin, Viviana. Hospital de Niños Ricardo Gutierrez, Epidemiología, Buenos Aires; Argentina.es
dc.descriptionFil: Regueira, Mabel. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.es
dc.descriptionFil: Chiavetta, Laura. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.es
dc.descriptionFil: Agudelo, Clara Inés. Instituto Nacional de Salud, Bogotá; Colombia.es
dc.descriptionFil: Castañeda, Elizabeth. Instituto Nacional de Salud, Bogotá; Colombia.es
dc.descriptionFil: De la Hoz, Fernando. Facultad de Medicina, Departamento de Salud Pública, Universidad Nacional de Colombia, Bogotá; Colombia.es
dc.descriptionFil: Higuera, Ana Betty. Secretaria de Salud de Bogotá, Bogotá; Colombia.es
dc.descriptionFil: Arce, Patricia. Secretaria de Salud de Bogotá, Bogotá; Colombia.es
dc.descriptionFil: Cohen, Adam L.. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA; Estados Unidos.es
dc.descriptionFil: Verani, Jennifer. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA; Estados Unidos.es
dc.descriptionFil: Zuber, Patrick. Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva; Suiza.es
dc.descriptionFil: Gabastou, Jean-Marc. Pan American Health Organization, Washington DC; Estados Unidos.es
dc.descriptionFil: Pastor, Desiree. Pan American Health Organization, Washington DC; Estados Unidos.es
dc.descriptionFil: Flannery, Brendan. Pan American Health Organization, Washington DC; Estados Unidos.es
dc.descriptionFil: Andrus, Jon. Pan American Health Organization, Washington DC; Estados Unidos.es
dc.description.abstractTo inform World Health Organization recommendations regarding use of Haemophilus influenzae type b (Hib) vaccines in national immunization programs, a multi-country evaluation of trends in Hib meningitis incidence and prevalence of nasopharyngeal Hib carriage was conducted in four South American countries using either a primary, three-dose immunization schedule without a booster dose or with a booster dose in the second year of life. Surveillance data suggest that high coverage of Hib conjugate vaccine sustained low incidence of Hib meningitis and low prevalence of Hib carriage whether or not a booster dose was used.es
dc.language.isoenes
dc.publisherVaccinees
dc.relation.ispartofVaccinees
dc.rightsClosedAccessen_US
dc.sourceVaccine 2012; 30(2):486-492en_US
dc.subjectHaemophilus influenzae tipo bes
dc.subjectVacuna Neumocócica Conjugada Heptavalentees
dc.subjectEsquemas de Inmunizaciónes
dc.subjectAmérica Latinaes
dc.titleImpact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countrieses
dc.typeArtículoes
dc.identifier.doihttps://www.sciencedirect.com/science/article/pii/S0264410X11017518?via%3Dihub-
item.openairetypeArtículo-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
Appears in Collections:Preproducción
Publicaciones INEI
Files in This Item:
File Description SizeFormat
Vaccine,30,2012,486–492.pdf280.47 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

53
checked on Mar 29, 2024

Download(s)

20
checked on Mar 29, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.